Le Registre des lobbyistes
Nombre total de rapports de communication : 5
Rapports mensuels de communications au cours des 6 derniers mois : 0
| Objets | Détails | Catégories |
|---|---|---|
|
Développement économique, Affaires étrangères, Marchés publics, Santé, Industrie, Relations internationales, Commerce international, Sécurité nationale/sécurité, Sciences et technologies
|
Canadian-United States-Mexico Agreement (CUSMA) with respect to provisions relating to medical devices and technologies
|
Proposition législative, Projet de loi ou résolution, Politique ou Programme, Règlement
|
|
Budget, Relations fédérales-provinciales, Marchés publics, Santé, Industrie
|
Discuss policies around healthcare system resiliency, infection prevention, medication errors, women's health, and health equity
|
Règlement, Politique ou Programme
|
|
Développement économique, Relations fédérales-provinciales, Marchés publics, Santé, Industrie, Sciences et technologies, Impôts et finances
|
Federal budget with respect to medical technology and device innovation and adoption, support and delivery of new models of care, equitable healthcare access, women’s health, and investments in long-term care and home care
|
Proposition législative, Projet de loi ou résolution
|
|
Développement économique, Marchés publics, Santé, Industrie, Sciences et technologies
|
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
|
Politique ou Programme
|
|
Développement économique, Santé, Industrie, Recherche et développement, Sciences et technologies
|
Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.
|
Politique ou Programme
|
|
Développement économique, Marchés publics, Santé, Industrie, Commerce international, Recherche et développement, Sciences et technologies
|
Federal life sciences strategy with respect to global value chain and supply chain management and investment towards medical technology manufacturing and export.
|
Politique ou Programme, Proposition législative, Projet de loi ou résolution, Règlement
|
|
Relations fédérales-provinciales, Santé, Industrie
|
Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and diagnostic testing.
|
Politique ou Programme
|
|
Santé, Industrie, Sciences et technologies
|
Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies
|
Règlement
|
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and increase access to care through new models of healthcare delivery.
Ivy Parks, President
Adresse :
2100 Derry Road West
Mississauga, ON L5N 0B3
Canada
Numéro de téléphone :
905-288-6000
Becton Dickinson Canada Inc ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement